Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)
Price and Volume
Detailed Quote| Volume | 3,164,607 |
| Open | 38.57 |
| Bid (Size) | 38.30 (300) |
| Ask (Size) | 42.82 (300) |
| Prev. Close | 38.39 |
| Today's Range | 38.31 - 39.13 |
| 52wk Range | 24.05 - 41.24 |
| Shares Outstanding | 388,132,400 |
| Dividend Yield | 2.26% |
Top News
More News
Performance
| YTD |
+50.9%
|
+50.9%
|
| 1 Month |
+5.6%
|
+5.6%
|
| 3 Month |
+7.2%
|
+7.2%
|
| 6 Month |
+19.9%
|
+19.9%
|
| 1 Year |
+47.4%
|
+47.4%
|
More News
Read More
3 Low-Volatility Stocks We Find Risky
November 16, 2025
Via StockStory
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings?
November 12, 2025
Via StockStory
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
How Do Investors Really Feel About Royalty Pharma? ↗
September 16, 2025
Via Benzinga
Via MarketMinute
Topics
Intellectual Property
Royalty Pharma Reports Third Quarter 2025 Results
November 05, 2025
From Royalty Pharma plc
Via GlobeNewswire
What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings
November 03, 2025
Via StockStory
Topics
Artificial Intelligence
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks ↗
October 31, 2025
Via MarketBeat
2 Reasons to Avoid RPRX and 1 Stock to Buy Instead
October 29, 2025
Via StockStory
1 Trial, 2 Franchises: Zenas Stock Climbs on Landmark Data ↗
October 28, 2025
Via MarketBeat
Royalty Pharma Declares Fourth Quarter 2025 Dividend
October 17, 2025
From Royalty Pharma plc
Via GlobeNewswire
3 Healthcare Stocks We Keep Off Our Radar
October 13, 2025
Via StockStory
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
September 29, 2025
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
September 19, 2025
From Royalty Pharma plc
Via GlobeNewswire
1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore
September 17, 2025
Via StockStory
Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market
September 10, 2025
From Royalty Pharma plc
Via GlobeNewswire
Frequently Asked Questions
Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 38.92
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 11/21/25 04:00 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 15.11B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>